Mukka Proteins Ltd Extends Losing Streak to Three Sessions, Touches All-Time Low

Price Action and Market Performance

The stock's recent trajectory has been sharply downward, with a 9.3% loss over the past three sessions and a 6.14% drop on the day of the new low. This underperformance is stark compared to the Sensex's 2.42% decline on the same day and the Aquaculture sector's 2.02% fall. Over the last year, Mukka Proteins Ltd has shed 43.43%, a significant underperformance relative to the Sensex's 7.25% gain. The stock is trading below all key moving averages (5, 20, 50, 100, and 200 days), reinforcing the prevailing bearish momentum. what is driving such persistent weakness in Mukka Proteins Ltd when the broader market is in rally mode?

Valuation Metrics Reflect Caution

Despite the steep price decline, valuation multiples for Mukka Proteins Ltd remain moderate. The trailing twelve months P/E ratio stands at 13x, while the price-to-book ratio is 1.33x. Enterprise value multiples show EV/EBITDA at 10.45x and EV/Sales at 0.79x, indicating the stock trades at a discount relative to many peers in the FMCG sector. The EV to Capital Employed ratio of 1.15x suggests the market values the company’s capital base conservatively. However, the absence of dividend payouts and a PEG ratio marked as not applicable highlight limited shareholder returns and growth visibility. should you be looking at Mukka Proteins Ltd as a potential entry point or is there more downside ahead?

Quarterly Financials Show Mixed Signals

The latest quarterly results for December 2025 reveal a notable turnaround in profitability after seven consecutive quarters of losses. Net sales reached a record Rs 653.50 crores, while PBDIT surged to Rs 45.44 crores, also a high watermark. Profit after tax (PAT) doubled compared to the previous four-quarter average, standing at Rs 23.75 crores, reflecting a 101.1% increase. However, interest expenses also rose to Rs 14.56 crores, the highest recorded, which tempers the overall improvement. This juxtaposition of rising profits and elevated financing costs illustrates the complex financial position of Mukka Proteins Ltd. does the sell-off in Mukka Proteins Ltd represent an overreaction, or is the market seeing something the headline numbers don't show?

Quality and Capital Structure Concerns

Long-term quality metrics for Mukka Proteins Ltd remain subdued. The company has experienced a negative compound annual growth rate of -4.98% in operating profits over five years, alongside a 5-year sales decline of -3.07%. The average EBIT to interest coverage ratio is a weak 2.87x, while the debt to EBITDA ratio is elevated at 4.93x, signalling significant leverage. Net debt to equity stands at 1.25, indicating a highly leveraged balance sheet. Return on capital employed (ROCE) and return on equity (ROE) averages of around 10% further underline modest profitability. Institutional investors have reduced their stake by 1.5% in the previous quarter, now holding just 1.86%, which may reflect cautious sentiment among sophisticated market participants. how much does the low institutional participation weigh on the stock’s prospects at this level?

Technical Indicators Confirm Bearish Momentum

The technical landscape for Mukka Proteins Ltd is predominantly bearish. The stock trades below all major moving averages, with the current trend officially classified as bearish since 24 Mar 2026. Key indicators such as MACD and Bollinger Bands signal downward pressure, while RSI shows no clear signal on the weekly chart but is bullish monthly. On-balance volume (OBV) and Dow Theory indicators also lean bearish. Immediate support lies at Rs 20.20, the 52-week low, with resistance levels at Rs 21.64 (20-day moving average) and Rs 23.59 (100-day moving average). Delivery volumes have surged recently, with a 126% increase on the last trading day compared to the 5-day average, suggesting heightened trading activity amid the sell-off. is this a genuine recovery or a relief rally that will fade at the 20 DMA?

Balancing the Bear Case and Silver Linings

The steep decline in Mukka Proteins Ltd shares reflects a combination of weak long-term fundamentals, high leverage, and subdued institutional interest. The company’s negative growth trends over five years and modest returns on capital suggest structural challenges. Yet, the recent quarterly turnaround with record sales and profit growth introduces a degree of complexity to the narrative. The valuation multiples remain relatively attractive compared to peers, and the stock trades near historic lows, which may warrant attention from value-focused investors. Should you buy, sell, or hold at these levels? Explore the complete multi-factor analysis of Mukka Proteins Ltd to find out what the data signals at this all-time low.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →